background: Polycystic ovary syndrome (PCOS) is closely associated with obesity but the prevalence of obesity varies between published studies. The objective of this research was to describe the prevalence of overweight, obesity and central obesity in women with and without PCOS and to assess the confounding effect of ethnicity, geographic regions and the diagnostic criteria of PCOS on the prevalence. methods: MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL) and PSYCINFO were searched for studies reporting the prevalence of overweight, obesity or central obesity in women with and without PCOS. Data were presented as prevalence (%) and risk ratio (RR) [95% confidence interval (CI)]. Random-effect models were used to calculate pooled RR. Human Reproduction Update, Vol.18, No.6 pp. 618-637, 2012 Advanced Access publication on July 4, 2012 doi:10.1093/humupd/dms030 now required to determine the source of this heterogeneity. Clinical management of PCOS should include the prevention and management of overweight and obesity.
Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. The National Institutes of Health (NIH) defined PCOS as the presence of hyperandrogenism and anovulation (Zawadski and Dunaif, 1992) , while the more recent European Society for Human Reproductive and Embryology/American Society for Reproductive Medicine (ESHRE/ASRM) criteria included those with polycystic ovaries on ultrasound (Broekmans et al., 2006) . The prevalence of PCOS varies according to the diagnostic criteria used, with estimates of 4-7% in women of reproductive age using the NIH criteria for PCOS (Knochenhauer et al., 1998; Diamanti-Kandarakis et al., 1999; Asuncion et al., 2000; Azziz et al., 2004b) and up to 15 -18% for the ESHRE/ASRM criteria (March et al., 2010; Mehrabian et al., 2011) .
PCOS is associated with reproductive, metabolic and psychological dysfunction including anovulatory infertility, increased risk of the metabolic syndrome (Hudecova et al., 2011) , impaired glucose tolerance (Ehrmann et al., 1999; Legro et al., 1999; Norman et al., 2001; Moran et al., 2010) , type 2 diabetes (Ehrmann et al., 1999; Legro et al., 1999; Moran et al., 2010) , cardiovascular diseases (Meyer et al., 2005; de Groot et al., 2011) and anxiety and depression (Himelein and Thatcher, 2006; Upadhya and Trent, 2007; Deeks et al., 2010; Li et al., 2011) . It was estimated that over $4 billion per year in the USA were spent on PCOS and its co-morbidities, identifying PCOS as a significant economic burden to health care (Azziz et al., 2005) .
PCOS is closely associated with obesity. Obesity worsens hyperandrogenism (Kiddy et al., 1990; Holte et al., 1994; Balen et al., 1995; Liou et al., 2009) and menstrual disturbances (Kiddy et al., 1990; Balen et al., 1995; Liou et al., 2009) in PCOS. Given the association between obesity and these clinical diagnostic features, PCOS may also be more prevalent among overweight and obese women. In support of this, a study in Spain reported that 28% of overweight and obesity women were diagnosed with PCOS (Alvarez- . Overweight and obese women with PCOS may present with a worse reproductive clinical presentation and are therefore more likely to be diagnosed, potentially contributing to an overexaggeration of the association between obesity and PCOS.
In addition to potentially increased risk for obesity in PCOS, women with PCOS are also more likely to carry excess adiposity in the central body region compared with body mass index (BMI)-matched controls (Strowitzki et al., 2002; Cosar et al., 2008; Svendsen et al., 2008; Carmina et al., 2009a; Godoy-Matos et al., 2009; Karabulut et al., 2011) . Central or visceral obesity is associated with greater insulin resistance (Lord et al., 2006; Cosar et al., 2008; Kalra et al., 2009; Karabulut et al., 2011) . In keeping with the key role of insulin resistance in the pathophysiology of PCOS, central obesity worsens the insulin-related metabolic and reproductive features of PCOS including hyperandrogenemia (Cosar et al., 2008; Svendsen et al., 2008; Godoy-Matos et al., 2009) , anovulation (Carmina et al., 2009a) and dyslipidemia (Pasquali et al., 1994; Lord et al., 2006) .
Despite the close association between PCOS and obesity, the prevalence of obesity in women with PCOS is highly variable. Obesity prevalence is known to differ according to age, ethnicity and geographic regions in the general population (Reynolds et al., 2007; Flegal et al., 2010) . Women with PCOS, as defined by the NIH criteria, may also have higher body weight compared with those identified using the ESHRE/ASRM criteria or non-NIH phenotypes . Current understanding on the overall prevalence of obesity in women with PCOS is limited by the lack of representative population-based data. Therefore, the objective of this systematic review and meta-analysis was to provide an evidence-based assessment of the prevalence of overweight and obesity, obesity and central obesity in women with PCOS and to assess the confounding effect of age, ethnicity, geographic region and the diagnostic criteria of PCOS on the prevalence.
Methods

Identification of studies and eligibility criteria
Search strategy
We searched the following electronic databases: MEDLINE, EMBASE, CINAHL, PSYCINFO and the Cochrane Central Register of Controlled Trials (CENTRAL). All articles published before November 2010 was considered for eligibility. Only articles published in the English language were included. The search strategy as shown in Supplementary data, Table SI was constructed for MEDLINE. Equivalent subject headings were used for the searches in other databases. In addition to the database search, all reviewers (i.e. co-authors) were asked to provide any potentially relevant studies for consideration.
Selection criteria
Two separate research questions were considered in this review: (i) the assessment of the prevalence of overweight and obesity, obesity and central obesity in women with PCOS and (ii) a comparison of the prevalence of overweight and obesity, obesity and central obesity in women with and without PCOS. All studies of women with PCOS, with or without a control group, were considered for eligibility. We included studies in which the prevalence of overweight and obesity, obesity or central obesity was available or determinable. We included studies where women with PCOS were either consecutively recruited or randomly sampled. We excluded studies where participants were selected by body weight, BMI, waist circumference (WC) or waist -hip ratio (WHR). For study inclusion, PCOS was defined according to the NIH (Zawadski and Dunaif, 1992) or ESHRE/ASRM (Broekmans et al., 2006) criteria. For studies comparing the prevalence of overweight and obesity in women with and without PCOS, the control subjects were not diagnosed with PCOS and were not weight-or BMI matched to the PCOS subjects. For studies comparing the prevalence of central obesity in women with and without PCOS, the control subjects were not diagnosed Obesity and central obesity in PCOS with PCOS and were not matched to their cases by WC or WHR. Overweight and obesity in adults was defined by the World Health Organization (WHO) criteria (BMI ≥25 kg/m 2 for overweight and obesity, BMI ≥30 kg/m 2 for obesity; WHO, 2000) . In studies on Asian subjects, overweight and obesity was defined as a BMI ≥23 kg/m 2 and obesity was defined as a BMI ≥25 kg/m 2 according to the International Obesity Task Force (IOTF; WHO, 2000) . For adolescents, overweight was defined as 85th to 95th percentile and obesity as ≥95th percentile in the age -gender specific percentile distributions for BMI in the Centers for Disease Control and Prevention growth charts (Barlow, 2007 
Data extraction
General study characteristics (author, year of publication, study location, study period, study design, number of women with and without PCOS), characteristics of the study population (recruitment source, sampling method, age, ethnicity), definition of PCOS (NIH or ESHRE/ASRM), preexisting medication use, physical activity and diet history, definition of obesity (WHO, IOTF) and central obesity (IDF, ATPIII, WHO), measurement of height, weight and WC, and the proportion of women who were overweight and obese, obese or centrally obese were extracted from all included studies. One reviewer extracted the data from all articles, while another independently extracted the data from 10% of the studies identified through random selection. Inter-reviewer agreement of 0.91 was reached. Discrepancies were resolved by consensus.
Quality assessment
Quality of the included studies was assessed using criteria based on the Newcastle-Ottawa scale for non-randomized studies (Wells et al., 2010) . These criteria assessed the selection of PCOS and control groups, comparability of PCOS and control groups, and the quality of outcome measurement. One reviewer assessed all the articles, while another independently appraised 10% of the studies identified through random selection. Inter-reviewer agreement of 0.86 was reached, and disagreement was resolved by consensus.
Outcomes of interest
The primary a priori end-points were the prevalence of overweight and obesity, obesity and central obesity in women with PCOS and a comparison of the prevalence in women with and without PCOS. The secondary a priori end-point was the prevalence of overweight and obesity, obesity or central obesity in women with and without PCOS according to the study quality score, PCOS diagnostic criteria, age, ethnicity and geographic region.
Data analysis
The proportion of women with PCOS with overweight and obesity, obesity or central obesity was expressed as a percentage. A contourenhanced funnel plot was conducted to assess a risk of publication bias. Pooled estimates with 95% confidence interval (CI) of the prevalences for overweight and obesity, obesity and central obesity were calculated using random-effects meta-analysis in STATA 11.2. The risks of overweight and obesity, obesity or central obesity in women with PCOS compared with women without PCOS were expressed as risk ratio (RR) with 95% CI. Data were combined for meta-analysis with the use of the MantelHaenszel random effects model owing to the presence of clinical and/or statistical heterogeneity. Heterogeneity between the studies was examined by x 2 tests for significance (P , 0.1 was considered statistically significant).
Inconsistency between studies was quantified using I 2 tests (I 2 ,25% was considered low heterogeneity, I 2 .50% was considered substantial heterogeneity). A priori subgroup analyses were conducted to assess heterogeneity, including the study quality score, PCOS diagnostic criteria, age, ethnicity and geographic region. Differences between the subgroups were assessed using the method described by Borenstein et al. (2008) . Data analyses were performed using RevMan 5.1 (2011).
Results
Characteristics of included studies and quality assessment
The search yielded 9874 citations as shown in Supplementary data, Fig. S1 . Based on our selection criteria, 1485 studies were identified for further assessment in full text. Of these, 188 studies were excluded because PCOS diagnosis was not consistent with NIH or ESHRE/ ASRM criteria, 178 because definition of overweight and obesity was not consistent with WHO criteria, 670 had insufficient data to determine the prevalence of obesity or central obesity, in 234 patients with PCOS were not consecutively or randomly sampled, in 91 patients were selected based on BMI or body weight, 1 had a definition of central obesity inconsistent with IDF, ATP III or WHO criteria, 7 were not in English and 10 had duplicated data. Finally, 106 studies were included for the systematic review for the first research question of assessing the prevalence of overweight and obesity, obesity and central obesity in women with PCOS. From these studies, 71 were excluded from the meta-analysis owing to lack of a control group that was not BMI-or body-weight matched to the PCOS group. Finally, 35 studies were included in the meta-analysis for the second research question of comparing the prevalence of overweight and obesity, obesity and central obesity in women with and without PCOS.
Characteristics of the included studies are shown in Tables I and III. The majority of studies (70%) used a cross-sectional design. Of the studies that reported their sampling frame, all except for two (Hashemipour et al., 2004; Yildiz et al., 2008) recruited their patients from a hospital or clinic. A hundred and one studies reported the prevalence of overweight and obesity, of which 32 studies included a control group (Table III) . Eleven studies reported the prevalence of central obesity, of which six included a control group (Table III) Ciampelli et al., 1999; Cupisti et al., 2007a; Chhabra and Venkatraman, 2010; Dewailly et al., 2010; Farid ur et al., 2010) and four studies that included adolescents only (Glueck et al., 2001 (Glueck et al., , 2006a (Glueck et al., , 2008a Hashemipour et al., 2004) . Forty-three studies used a diagnosis consistent with the NIH criteria, while 63 used a diagnosis consistent with the ESHRE/ASRM criteria (Table III) . In terms of the geographic region, 31 studies were conducted in the Americas, 45 in Europe, 28 in Asia and 2 in Oceania. Thirty-seven studies reported ethnicity for women with PCOS. The WHO-IOTF definition of overweight and obesity were used for the seven studies conducted in Asian women (Table III) . Seven studies described the measurement of body height and weight, 14 studies reported the diet and physical activity of the subjects and 69 studies reported on the use of medication that could affect the study outcome (Supplementary data, Table SII ). Further description of the studies is reported in Supplementary data, Table SII . Supplementary data, Table SIII reports the quality assessment of the studies using criteria based on the Newcastle-Ottawa scale. As determined by our inclusion criteria, all women with PCOS were recruited either consecutively or randomly. All controls were recruited from hospitals or clinics except in nine studies (Glueck et al., 2005b (Glueck et al., , 2006b (Glueck et al., , 2009 Hahn et al., 2005; Hahn et al., 2007; Vrbikova et al., 2007; Mukherjee et al., 2009; Wang et al., 2009) . Most studies (98%) provided adequate criteria for the diagnosis of PCOS, except in two studies (Shroff et al., 2007; Altieri et al., 2010) which relied on record linkage data or self-reported data. Outcome (i.e. body weight, height, WC and/or hip circumference) was independently measured in 56 studies (Supplementary data, Table SIII ). Twenty-two of the 35 studies with control groups reported that the same method was used to ascertain the outcomes in both groups. Six studies (Ferk et al., 2007; Chae et al., 2008; Cheung et al., 2008; Mukherjee et al., 2009; Wang et al., 2009; Altieri et al., 2010) included controls with no feature of PCOS. Comparability between the groups in terms of age or other factors (e.g. socioeconomic status) was met in 21 studies. No study reported on the non-response rate for the women with or without PCOS. Seventeen studies were categorized as being higher quality (≥5/9) and 89 studies were categorized as being lower (≤4/9) quality (Supplementary data, Table SIII) .
A contour-enhanced funnel plot was conducted to assess the risk of publication bias. For studies on overweight and obesity (Supplementary data, Fig. S2 ), the plot was asymmetric (P-value of the test for symmetric funnel plot, arcsine test ¼ 0.015). The arcsine test proposed by Rucker et al. (2008) was conducted since neither the Egger's (Egger et al., 1997) nor Harbord's (Harbord et al., 2006) test was appropriate. The Egger's test is used for continuous endpoints and the Harbord's (or modified Egger's test) is not recommended for a review with large imbalance in the group sizes and/or with substantial heterogeneity. A publication bias could not be excluded for studies on overweight and obesity, although true heterogeneity in effect sizes would be another source of asymmetry in the funnel plot (Egger et al., 1997) . For studies on obesity, the contourenhanced funnel plot was relatively symmetric (Supplementary data, Fig. S3 , P value ¼ 0.39). Given true heterogeneity in effect sizes, a publication bias is unlikely. The impact of potential future studies on the meta-analysis was assessed using the method proposed by Langan et al. (2012) . The significant contours indicated very little chance that any additional studies would change the pooled finding to statistical non-significance. The finding of the current meta-analysis would be altered if, and only if, an additional study of enormous sample size which is far more than the largest study ever conducted [(Glueck et al., 2005b) with SE of 0.06] provides significant negative effect. It is thus concluded that the meta-analysis finding is robust.
Prevalence of overweight and obesity (BMI ≥25 kg/m 2 ), obesity (BMI ≥30 kg/m 2 and central obesity
The proportion of women with PCOS who were overweight and obese ranged from 6% (Ansarin et al., 2007) to 100% (Peppard et al., 2001; Glueck et al., 2003b; Villaseca et al., 2004) with a pooled estimated prevalence of 61% (95% CI: 54 -68%). In the 21 studies that provided data on the prevalence of overweight and obesity in women with and without PCOS, the prevalence of overweight and obesity was significantly higher in women with PCOS ( Fig. 1 ). Significant statistical heterogeneity was present. The prevalence of obesity in women with PCOS ranged from 12.5% (de Vries et al., 2007) to 100% (Peppard et al., 2001 ) with a pooled estimated prevalence of 49% (95% CI: 42-55%). In the 18 studies that provided data on the prevalence of obesity in women with and without PCOS, the prevalence of obesity was significantly higher in women with PCOS (Fig. 2) . Significant statistical heterogeneity was present.
The prevalence of central obesity in women with PCOS ranged from 20% (Gul et al., 2008) to 85.5% (Glueck et al., 2003b ) with a pooled estimated prevalence of 54% (95% CI: 43-62%). In the six studies that provided data on the prevalence of central obesity in Obesity and central obesity in PCOS women with and without PCOS, the prevalence of central obesity was significantly higher in women with PCOS (Fig. 3) . There was significant statistical heterogeneity.
Subgroup analyses to assess potential sources of heterogeneity
Quality score
Subgroup analyses were performed for studies with a higher (≥5/9) or lower (≤4/9) study quality score (Table II) . Significant statistical heterogeneity was found in all comparative subgroups for quality score. There was a trend for the association between PCOS and overweight and obesity being stronger in studies with a higher score compared with those with a lower score. The association between PCOS and obesity was stronger in studies with a higher score compared with those with a lower score. The association between PCOS and central obesity was similar in studies with higher and lower scores.
PCOS diagnosis
Subgroup analyses were performed for studies with PCOS diagnosis consistent with the NIH or ESHRE/ASRM criteria (Table II) . Significant statistical heterogeneity was found in all comparative subgroups for PCOS diagnosis, except in the NIH subgroup for the prevalence of central obesity. The association between PCOS status and overweight and obesity was similar in both NIH and ESHRE/ASRM subgroups. The association between PCOS status and obesity was not different between the NIH and ESHRE/ASRM subgroups. The prevalence of central obesity was similar in the NIH and ESHRE/ASRM subgroups.
Age
Subgroup analyses were performed on studies with adolescents or adults (Table II) . Significant statistical heterogeneity was present in all comparative subgroups for age. The association between PCOS status and overweight and obesity was similar in adults and adolescents. Adolescent girls with PCOS appeared to have a greater prevalence of obesity than adult women with PCOS but the difference did not reach statistical significance. Subgroup analyses were not performed for studies conducted in adolescents as all studies comparing the prevalence of central obesity in women with and without PCOS were conducted in adults.
Ethnicity
Subgroup analyses were performed on studies involving the Caucasian women or Asian women (Table II) . Significant statistical heterogeneity was observed in all comparative subgroups for ethnicity, except in the Caucasian subgroup for the prevalence of central obesity. The association between PCOS and overweight and obesity was similar in both subgroups. The RR for obesity was higher in the Caucasian women than that of the Asian women. The prevalence of central obesity was similar in both Caucasian and Asian subgroups.
Geographic region
Subgroup analyses were performed across geographic regions, including Americas, Europe and Asia (Table II) . Significant statistical heterogeneity was seen in all comparative subgroups for the geographic region. The association between PCOS status and overweight and obesity was not significantly different between Americas, Europe and Asia subgroups. The association between PCOS status and obesity was similar in all three regions. The association between PCOS status and central obesity was similar in all three regions.
Discussion
Principal findings
We report a comprehensive systematic review and meta-analysis of the prevalence of overweight and obesity, obesity and central obesity in women with and without PCOS. We found that women with PCOS had significantly elevated prevalence for overweight and obesity, obesity and central obesity, compared with controls. When only studies with high quality scores were considered, the RRs for being overweight and obese were even higher. The increased risk of being overweight and obese for women with PCOS was independent of PCOS diagnostic criteria, age and geographic region. The Caucasian women with PCOS had a greater prevalence of obesity than that of Asian women with PCOS.
Interpretation of findings
The primary aim of this review was to report on the prevalence of obesity in women with and without PCOS. It has been proposed that obesity plays an important role in the pathogenesis of PCOS. 1995; Liou et al., 2009) . In the long term, overweight or obese women with PCOS had increased risk of developing metabolic syndrome, impaired glucose tolerance and type 2 diabetes (Legro et al., 1999; Ehrmann et al., 2006) . Obesity may also contribute to the psychological co-morbidities in women with PCOS, such as anxiety and depression (Himelein and Thatcher, 2006; Barry et al., 2011) . One study has shown that weight gain precedes the onset of PCOS (Laitinen et al., 2003) , lending further support to the causal role of obesity in the development of PCOS but this remains to be confirmed in further longitudinal studies.
The effect of obesity on the metabolic and reproductive symptoms in PCOS is likely to be mediated by insulin resistance (DiamantiKandarakis, 2007) . Obesity, particularly central obesity, is known to increase insulin resistance (Carey et al., 1996; Tousignant et al., 2008) . Hyperinsulinemia resulting from insulin resistance stimulates ovarian steroidogenesis and inhibits sex hormone-binding globulin (SHBG) production in the liver, thereby increasing the availability of free androgens (Plymate et al., 1988) . The adipose tissue also provides storage and a metabolic site for various lipid-soluble steroids, such as androgens, which contributes further to hyperandrogenism (Pasquali et al., 2006) . Women with PCOS who are more overweight and obese are therefore more likely to have a worse clinical reproductive presentation, with the resulting potential for an earlier diagnosis.
There is also evidence suggesting that PCOS contributes to obesity. Women with high androgen levels independent of PCOS status were found to have greater cravings for high-fat foods and carbohydrate-rich foods (Lim et al., 2009) and possibly a greater intake of these foods (Douglas et al., 2006) . However, this was not found in all studies (Alvarez Blasco et al., 2011) . Metabolic factors, such as hyperinsulinemia (Aas et al., 2009) , reduced postprandial thermogenesis (Robinson et al., 1992) and basal metabolic rate (Georgopoulos et al., 2009 ) and alterations in (Baranowska et al., 1999; Hirschberg et al., 2004; Moran et al., 2004 Moran et al., , 2007 , could also contribute to weight gain in women with PCOS. The greater prevalence of overweight and obesity in PCOS may therefore additionally reflect an inherent predisposition to weight gain. It is not clear from this current study whether PCOS primarily contributes to obesity or obesity primarily contributes to PCOS.
Women with PCOS have greater tendency to accumulate fat in the upper body when compared with controls matched for weight or BMI (Kirchengast and Huber, 1999; Yucel et al., 2006; Svendsen et al., 2008) . This effect could be present even in lean women with PCOS (Carmina et al., 2007; Svendsen et al., 2008) . Central adiposity was associated with more severe metabolic and reproductive features of PCOS including hyperandrogenism (Pasquali et al., 1994; Cosar et al., 2008; Svendsen et al., 2008; Godoy-Matos et al., 2009) , higher insulin levels (Pasquali et al., 1994) , lower SHBG levels (Lord et al., 2006) and dyslipidemia (Pasquali et al., 1994; Lord et al., 2006; Wehr et al., 2009; Penaforte et al., 2010) . On the other hand, high levels of insulin and androgens may potentially encourage a central body fat distribution (Sinha et al., 1996; Janssen et al., 2010) , which could explain the greater risk of central obesity in women with PCOS. This could form a vicious cycle perpetuating the centrally obese state of women with PCOS. It is again not possible to determine from the current review whether the elevated prevalence of central obesity in PCOS primarily reflects an effect of PCOS on worsening central obesity or an effect of central obesity on worsening PCOS.
In addition to the potential confounders of obesity mentioned above, methodological factors, such as study design, definition of PCOS, sampling frame and measurement of obesity, could also influence the estimate of obesity prevalence. To account for these effects, we performed a subgroup analysis according to study quality scores. We found that studies with higher quality scores had higher obesity prevalence, which lends further support to our conclusion that women with PCOS had a greater prevalence of obesity. This also suggests that the pooled prevalence that included all studies is likely to be an underestimation of obesity risk for women with PCOS.
The secondary aim of this review was to examine the effect of PCOS diagnostic criteria, age, ethnicity and geographic region on obesity prevalence in women with and without PCOS. NIH PCOS phenotypes were reported to have more severe metabolic and reproductive symptoms compared with the ESHRE/ASRM PCOS phenotypes (Carmina et al., 2005; Broekmans et al., 2006; Welt et al., 2006; Hsu et al., 2007; Lam et al., 2009; Cho et al., 2011) but this was not reported by all studies (Moran et al., 2011a, c) . Greater central obesity in NIH PCOS has also been previously reported in some studies (Welt et al., 2006; Barber et al., 2007; Hsu et al., 2007; Lam et al., 2009; Anaforoglu et al., 2011) but not in others (Hickey et al., 2011; Mehrabian et al., 2011; Tehrani et al., 2011) . Our meta-analysis suggests that the risk for obesity and central obesity was similar in patients diagnosed with PCOS using the NIH and the ESHRE/ASRM criteria.
The prevalence of obesity in girls aged 12-19 years in the USA in 2007-2008 was 17% , compared with 50 -80% among adolescent girls with PCOS over the similar time period (Glueck et al., 2006a (Glueck et al., , b, 2008a . Obesity and obesity-related co-morbidities are therefore of increasing relevance in adolescents. As seen in adults, greater adiposity (especially around the waist) was associated with lower insulin sensitivity, greater hyperandrogenemia, worse lipid profile and higher blood pressure in adolescents with PCOS (Silfen et al., 2003; Glueck et al., 2006b ). This may have serious long-term implications as elevated BMI during adolescence, even within the normal range, predicted the incidence of diabetes and coronary heart disease in adulthood (Tirosh et al., 2011) . Considering the risk of obesity (up to 6 times) among adolescents with PCOS compared with those without PCOS reported here, obesity interventions targeted at adolescents with PCOS are urgently needed.
While a difference in the prevalence of obesity according to geographic region or ethnicity is likely to be a result of the interaction between individual factors (e.g. genetic) and environmental factors (e.g. food supply; Swinburn et al., 2011) , an increased risk of obesity in the Caucasian women with PCOS compared with the Asian women with PCOS in this meta-analysis suggests a difference in the nature of PCOS between these groups, considering that their comparative groups were controls of the same ethnicity and geographic region. In this meta-analysis, the Caucasian women were from the USA and Europe while the Asian women were from China and Taiwan. Another study comparing Eastern Asian populations with American and European patients reported a similar trend (Carmina et al., 1992) . The same study also reported that the Japanese women with PCOS had lower body weight and fasting insulin levels compared with their American and Italian counterparts (Carmina Obesity and central obesity in PCOS et al., 1992) . Despite the lower obesity cut-off for Asians (WHO, 2000) used in this meta-analysis, the prevalence of obesity among the Asian women with PCOS was still significantly lower than that of the Caucasian women with PCOS. It is possible that the risk for PCOS escalates at an even lower BMI than the suggested cut-off point for the Asian women.
Strength and weaknesses
This is a comprehensive systematic review and meta-analysis on the subject of overweight, obesity and central obesity in women with PCOS. An extensive search was conducted to avoid missing any relevant information. Contour-enhanced funnel plots indicated that the results of this meta-analysis are robust and it is highly unlikely that additional studies would shift the results to non-significance. Significant clinical and statistical heterogeneity was present between the studies, indicating considerable variability in the data. This limits the applicability of our conclusions to all women with PCOS. Subgroup analyses were conducted to address the contribution of potential sources of clinical heterogeneity, such as age, ethnicity, PCOS diagnostic criteria and geographic region. However, the heterogeneity remained unexplained in most subgroups. Factors such as definition and recruitment of controls, sampling frame of PCOS women, physical activity, diet history, socio-economic status and family history of obesity may be sources of residual confounding. The omission of papers published in other languages may have also limited our ability to determine the association between PCOS and obesity in different ethnic groups. Despite this limitation, this meta-analysis reported a significant difference between the Caucasian and Asian women in the prevalence of obesity.
The optimal study design for the determination of obesity prevalence in women with and without PCOS would be a population study in which members of the general community were consecutively selected or randomly sampled in a way that would not bias the prevalence of obesity. Unfortunately, no study met these criteria. Most population studies in women with PCOS did not report the prevalence of obesity (Knochenhauer et al., 1998; Diamanti-Kandarakis et al., 1999; Asuncion et al., 2000; Azziz et al., 2004b; March et al., 2010) . Moreover, these studies tended to recruit their participants from public health campaigns, the university employment database, or blood donors lists (Knochenhauer et al., 1998; Diamanti-Kandarakis et al., 1999; Asuncion et al., 2000; Azziz et al., 2004b; March et al., 2010) . These sources may be overrepresented by disease-free, healthy-weight participants. Most participants included in studies in this review were recruited through convenience sampling, mostly from clinics or hospitals. Thus, the PCOS groups in this review may be over-represented by those with more severe symptoms and potentially with a higher BMI. However, controls recruited from these setting could also be less healthy, which would result in an underestimation of obesity risks for the PCOS group instead. To minimize the effects of further selection bias, we included only studies that recruited participants in a consecutive or random manner. There are potential biases inherent to the process of data extraction and quality assessment in this review, as most of the process was conducted by one reviewer, although good inter-rater agreements were achieved in the subset of papers extracted and assessed by the second reviewer. As this is a cross-sectional investigation, the directionality of event could not be determined. The question of whether obesity precedes PCOS is better addressed in longitudinal studies.
Clinical implications, research implications and future directions
Considering the high risk of overweight, obesity and central obesity in women with PCOS reported in this current study and the adverse effects of obesity on the disease, obesity management should play a central role in the treatment of PCOS. Lifestyle modification is recommended as a key initial treatment strategy in overweight and obese women with PCOS ; Jean Hailes Foundation for Women's Health on behalf of the PCOS Australian Alliance, 2011) and has been shown to improve hyperandrogenism, hirsutism, body weight, WC and insulin resistance in women with PCOS (Moran et al., 2011b) . There is a need for greater awareness on the increased risk of central obesity among PCOS patients, as this form of obesity could affect even those with a normal BMI. Overweight and obese adolescents with PCOS should also be advised to lose weight. This will not only assist with their immediate symptoms but also will help to prevent the development of diabetes and cardiovascular disease in adulthood. Lean women with PCOS should be cautioned of the high risk of overweight, obesity and central obesity associated with PCOS, and be encouraged to engage in health behaviors that prevent weight gain. This is important considering the trend for weight gain among women of reproductive age (Brown et al., 2006) . This review highlights the need for a representative population study reporting the prevalence of overweight, obesity and central obesity in women with and without PCOS. Future population studies should consider probability sampling, instead of convenience sampling, to minimize bias in their results (Kraschnewski et al., 2010) . This is particularly important in the estimation of obesity prevalence, which is confounded by numerous factors. Our findings support the positive association between obesity and PCOS but our conclusions are limited by the significant heterogeneity between studies. Further studies are required to determine the source of heterogeneity in this association. This is essential in identifying the target groups among women with PCOS for obesity intervention, such as the Caucasian women identified in this review. Studies comparing the features of PCOS in different ethnic groups may also be of interest and may reveal clinically significant findings for the management of PCOS. While we report an overall increased prevalence of overweight, obesity and central obesity among women with PCOS, it is still unclear if obesity is the cause or effect of the disease. Longitudinal studies are needed to elucidate the role of obesity in the pathogenesis of PCOS.
Conclusion
This systematic review showed that women with PCOS had a greater prevalence of overweight and obesity, obesity and central obesity compared with women without PCOS. The Caucasian women with PCOS had a greater risk for obesity than that of the Asian women with PCOS. Further research on interventions assessing the most effective means of preventing and treating obesity for women with PCOS of all ages is urgently needed.
